INDOUSOther Agricultural Products
Indo US Bio Tech Ltd — Profit & Loss Statement
₹98.21
-0.51%
Indo US Bio Tech Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | -0.01 Cr | — |
| Tax Rate For Calcs | 0.02 | 0.06 | 0.02 | 0.05 | — |
| Normalized EBITDA | 19.12 Cr | 11.10 Cr | 9.34 Cr | 7.17 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 0.00 | -0.27 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.00 | -0.27 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 16.27 Cr | 8.24 Cr | 7.24 Cr | 5.06 Cr | — |
| Reconciled Depreciation | 1.10 Cr | 0.80 Cr | 0.83 Cr | 0.45 Cr | — |
| Reconciled Cost Of Revenue | 72.66 Cr | 49.37 Cr | 45.74 Cr | 36.83 Cr | — |
| EBITDA | 19.12 Cr | 11.10 Cr | 9.34 Cr | 6.90 Cr | — |
| EBIT | 18.02 Cr | 10.30 Cr | 8.51 Cr | 6.46 Cr | — |
| Net Interest Income | -1.49 Cr | -1.51 Cr | -1.20 Cr | -1.20 Cr | — |
| Interest Expense | 1.49 Cr | 1.51 Cr | 1.12 Cr | 1.14 Cr | — |
| Normalized Income | 16.27 Cr | 8.24 Cr | 7.24 Cr | 5.32 Cr | — |
| Net Income From Continuing And Discontinued Operation | 16.27 Cr | 8.24 Cr | 7.24 Cr | 5.06 Cr | — |
| Total Expenses | 86.00 Cr | 62.85 Cr | 52.26 Cr | 43.39 Cr | — |
| Diluted Average Shares | 2.00 Cr | 2.01 Cr | 0.96 Cr | 1.22 Cr | — |
| Basic Average Shares | 2.00 Cr | 2.01 Cr | 0.96 Cr | 1.22 Cr | — |
| Diluted EPS | 8.12 | 4.11 | 7.51 | 4.13 | — |
| Basic EPS | 8.12 | 4.11 | 7.51 | 4.13 | — |
| Diluted NI Availto Com Stockholders | 16.27 Cr | 8.24 Cr | 7.24 Cr | 5.06 Cr | — |
| Net Income Common Stockholders | 16.27 Cr | 8.24 Cr | 7.24 Cr | 5.06 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 16.27 Cr | 8.24 Cr | 7.24 Cr | 5.06 Cr | — |
| Net Income Including Noncontrolling Interests | 16.27 Cr | 8.24 Cr | 7.24 Cr | 5.06 Cr | — |
| Net Income Continuous Operations | 16.27 Cr | 8.24 Cr | 7.24 Cr | 5.06 Cr | — |
| Tax Provision | 0.26 Cr | 0.55 Cr | 0.15 Cr | 0.25 Cr | — |
| Pretax Income | 16.53 Cr | 8.79 Cr | 7.39 Cr | 5.31 Cr | — |
| Other Non Operating Income Expenses | 0.18 Cr | 0.32 Cr | 12297.00 | 0.11 Cr | — |
| Special Income Charges | 0.00 | 0.00 | 0.00 | -0.27 Cr | — |
| Net Non Operating Interest Income Expense | -1.49 Cr | -1.51 Cr | -1.20 Cr | -1.20 Cr | — |
| Interest Expense Non Operating | 1.49 Cr | 1.51 Cr | 1.12 Cr | 1.14 Cr | — |
| Operating Income | 17.84 Cr | 9.98 Cr | 9.49 Cr | 6.66 Cr | — |
| Operating Expense | 13.34 Cr | 13.48 Cr | 6.52 Cr | 6.56 Cr | — |
| Other Operating Expenses | 11.15 Cr | 11.50 Cr | 0.58 Cr | 1.76 Cr | — |
| Depreciation And Amortization In Income Statement | 1.10 Cr | 0.80 Cr | 0.83 Cr | 0.45 Cr | — |
| Depreciation Income Statement | 1.10 Cr | 0.80 Cr | 0.83 Cr | 0.45 Cr | — |
| Gross Profit | 31.18 Cr | 23.46 Cr | 16.00 Cr | 13.23 Cr | — |
| Cost Of Revenue | 72.66 Cr | 49.37 Cr | 45.74 Cr | 36.83 Cr | — |
| Total Revenue | 103.84 Cr | 72.84 Cr | 61.74 Cr | 50.06 Cr | — |
| Operating Revenue | 103.84 Cr | 72.84 Cr | 61.74 Cr | 50.06 Cr | — |
| Interest Income | — | 0.01 Cr | 0.00 | 25635.00 | 16721.00 |
| Rent Expense Supplemental | — | 2.76 Cr | 1.73 Cr | 1.82 Cr | 0.98 Cr |
| Other Special Charges | — | 43401.00 | — | — | 0.01 Cr |
| Write Off | — | 0.09 Cr | 0.00 | 0.27 Cr | 0.01 Cr |
| Total Other Finance Cost | — | 0.11 Cr | 0.08 Cr | 0.06 Cr | 0.06 Cr |
| Interest Income Non Operating | — | 0.01 Cr | 0.00 | 25635.00 | 16721.00 |
| Research And Development | — | 5.49 Cr | 1.72 Cr | 2.03 Cr | 2.08 Cr |
| Selling General And Administration | — | 2.01 Cr | 1.98 Cr | 1.63 Cr | 2.65 Cr |
| Selling And Marketing Expense | — | 0.37 Cr | 0.12 Cr | 0.39 Cr | 1.63 Cr |
| General And Administrative Expense | — | 1.64 Cr | 1.86 Cr | 1.24 Cr | 1.02 Cr |
| Rent And Landing Fees | — | — | — | 36000.00 | 79200.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Indo US Bio Tech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.